Claudia Zylberberg

The Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) is a non-profit organization that connects the regenerative medicine community to the standards development process. With stakeholders from industry, academia, professional societies, and government entities, SCB occupies a unique niche within the regenerative medicine ecosystem and has no vested interests in a particular scientific, commercial, clinical, or policy approach. Our goal is to address stakeholder needs and support the advancement of standards that enhance the entire regenerative medicine community and accelerate innovation.

Kosten Digital creates personalized technology solutions to help life sciences organizations innovate, achieve operational excellence and exploit their data through AI. We meet our customers wherever they are in the journey from the earliest days of a new business to well-established, global corporations. We can help you: Transform your organization to make it more agile and innovative through technology Create digital products to evolve your organization Optimize your business processes reducing costs and increasing efficiencies Empower better decision-making by harnessing the power of data and Artificial Intelligence (AI) Simplify and secure your IT operations so that your team can focus on the business Assure global compliance throughout your processes

Liberty Science Center is a nonprofit organization dedicated to getting learners of all ages excited about the power, promise, and pure fun of science and technology. We are located in Liberty State Park on the Jersey City bank of the Hudson near the Statue of Liberty. The Science Center houses 12 museum exhibition halls, a live animal collection with 110 species, giant aquariums, the Jennifer Chalsty Planetarium (the biggest planetarium in the Western Hemisphere), a 3D theater, live simulcast surgeries, tornado and hurricane-force wind simulators, K-12 classrooms and labs, and teacher-development programs. More than half a million students, teachers, and parents visit the Science Center each year, and tens of thousands more participate in the Centers offsite and online programs. As a leading cultural institution in the NYC metropolitan area we are always looking for bright individuals with a can-do attitude that turn the impossible into the possible.

Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. The nine-month program employs an objectives-based mentoring process to enhance the performance of technical founders who learn from the insights of experienced entrepreneurs, with the goal of maximizing equity-value creation. Founded by Professor Ajay Agrawal in 2012 at the University of Toronto’s Rotman School of Management, the program has expanded and now has 11 sites across six countries: Toronto, Vancouver, Calgary, Montreal, Halifax, Paris, Madison, Seattle, Estonia, Berlin, and Melbourne. The program combines 5 elements to help companies transition from science projects to scalable and financeable companies: - An emphasis on objective-setting, helping companies focus on what’s most important to their business - Focused mentorship from experienced entrepreneurs who have founded, led, and sold significant tech companies - Technical advice from world-leading scientists, engineers, and economists - Hands-on support from top business students, who embed within the company to provide business support - Opportunities to raise capital, including angels and VCs from Europe and North America The successful commercialization of cutting-edge science and technology achieved through the program has led to the creation of over CAD $35 billion in equity value.

An innovative biotechnology company focused on providing its worldwide customers the best-in-class raw materials and components for superior research and product development. We develop and manufacture stem cell products, cell culture products, and cGMP tools and technologies for the cell therapy industry.

Arscience Bio’s team has over 20 years of experience in cytokine and immunomodulator development and manufacturing. We have built strong partnerships with leading academic institutions and clinical groups to develop novel indications for our portfolio of products. ​ With a strong Intellectual Property portfolio and established product supply capabilities, ARScience Bio is the ideal partner for in-vivo cell therapy applications of cytokines and immunomodulators.